VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 37 filers reported holding VERONA PHARMA PLC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $102,000 | -15.7% | 18,560 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $121,000 | -22.4% | 18,560 | -0.7% | 0.01% | -27.3% |
| Q1 2021 | $156,000 | +20.0% | 18,690 | +0.7% | 0.01% | 0.0% |
| Q4 2020 | $130,000 | -4.4% | 18,560 | -14.7% | 0.01% | -21.4% |
| Q3 2020 | $136,000 | +33.3% | 21,760 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $102,000 | +13.3% | 21,760 | 0.0% | 0.01% | +7.7% |
| Q1 2020 | $90,000 | -23.7% | 21,760 | +6.4% | 0.01% | -7.1% |
| Q4 2019 | $118,000 | +25.5% | 20,460 | 0.0% | 0.01% | +7.7% |
| Q3 2019 | $94,000 | +6.8% | 20,460 | +18.1% | 0.01% | 0.0% |
| Q2 2019 | $88,000 | -22.1% | 17,330 | 0.0% | 0.01% | -31.6% |
| Q1 2019 | $113,000 | – | 17,330 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |